戻る Agenda
Personalised Healthcare: A Systems Upgrade Worth Investing In?
Session Chair(s)
Nathalie Moll
Director General
European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium
Personalised Healthcare: A Systems Upgrade Worth Investing In?
Learning Objective : • Define and describe personalised healthcare (PHC) as a “systems upgrade” • Identify and apply parallels with previous healthcare system upgrades • Identify different stakeholder interests and concerns around upgrading to a PHC system • Develop consensus solutions for enabling PHC-systems, and clear calls to action
Speaker(s)
Vivek Muthu, MD, MA
Marivek Ltd., United Kingdom
Director
Panelist
Mark Lee
Genentech, Inc. , United States
SVP Global Head Personalized Health Care, Product Development
Panelist
Sarunas Narbutas
President, Lithuanian Cancer Patient Coalition, POLA, Lithuania
Chairman of Youth Cancer Europe (YCE)
Panelist
Anouk Waeytens, PHD, MSC
RIZIV-INAMI, Belgium
Senior Expert Pharmaceuticals